Bill Commons

CA SB 6

in committee

Controlled substances: xylazine.

California · 2025-2026 Regular Session · upper

Quick answers

Did CA SB 6 pass?

Not yet. CA SB 6 is in committee as of 2025-08-29 and has not come to a final vote. Latest recorded action (2025-08-29): August 29 hearing: Held in committee and under submission.

What is CA SB 6 about?

Existing law, the California Uniform Controlled Substances Act, categorizes controlled substances into 5 schedules and places the greatest restrictions on those substances contained in Schedule I. Under existing law, the substances in Schedule I are deemed to have a high potential for abuse and no accepted medical use while substances in Schedules II through V are substances that have an accepted medical use, but have the potential for abuse. Existing law restricts the prescription, furnishing, possession, sale, and use of controlled substances, and makes a violation of those laws a crime, except as specified. Existing law defines drug paraphernalia and prohibits, among other things, the manufacture, sale, and possession, as specified, of drug paraphernalia. Existing law excludes from these prohibitions any testing equipment that is designed, marketed, used, or intended to be used to analyze a substance for the presence of fentanyl, ketamine, gamma hydroxybutyric acid, or any analog of fentanyl. This bill would add xylazine to the list of Schedule III substances, as specified. If an animal drug containing xylazine that has been approved under the federal Food, Drug and Cosmetic Act is not available for sale in California, the bill would create an exception for a substance that is intended to be used to compound an animal drug, as specified. The bill would exclude from the prohibitions on paraphernalia any testing equipment to analyze a substance for the presence of xylazine. By creating a new crime, the bill would impose a state-mandated local program. The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement. This bill would provide that no reimbursement is required by this act for a specified reason.

Who sponsors CA SB 6?

Ashby is the primary sponsor of CA SB 6.

Description

Existing law, the California Uniform Controlled Substances Act, categorizes controlled substances into 5 schedules and places the greatest restrictions on those substances contained in Schedule I. Under existing law, the substances in Schedule I are deemed to have a high potential for abuse and no accepted medical use while substances in Schedules II through V are substances that have an accepted medical use, but have the potential for abuse. Existing law restricts the prescription, furnishing, possession, sale, and use of controlled substances, and makes a violation of those laws a crime, except as specified. Existing law defines drug paraphernalia and prohibits, among other things, the manufacture, sale, and possession, as specified, of drug paraphernalia. Existing law excludes from these prohibitions any testing equipment that is designed, marketed, used, or intended to be used to analyze a substance for the presence of fentanyl, ketamine, gamma hydroxybutyric acid, or any analog of fentanyl. This bill would add xylazine to the list of Schedule III substances, as specified. If an animal drug containing xylazine that has been approved under the federal Food, Drug and Cosmetic Act is not available for sale in California, the bill would create an exception for a substance that is intended to be used to compound an animal drug, as specified. The bill would exclude from the prohibitions on paraphernalia any testing equipment to analyze a substance for the presence of xylazine. By creating a new crime, the bill would impose a state-mandated local program. The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement. This bill would provide that no reimbursement is required by this act for a specified reason.

Introduced
2024-12-02
Latest action
2025-08-29 — August 29 hearing: Held in committee and under submission.
Bill type
bill
Last updated

Subjects

Sponsors

  • Ashbyauthor

Committees

Not provided by source.

Action timeline

  1. 2024-12-02

    Introduced. Read first time. To Com. on RLS. for assignment. To print.

    introduction,reading-1,referral-committee

  2. 2024-12-03

    From printer. May be acted upon on or after January 2.

  3. 2025-01-29

    Referred to Com. on PUB. S.

    referral-committee

  4. 2025-03-07

    Set for hearing March 25.

  5. 2025-03-25

    From committee: Do pass and re-refer to Com. on APPR. (Ayes 6. Noes 0. Page 532.) (March 25). Re-referred to Com. on APPR.

    committee-passage,committee-passage-favorable,referral-committee

  6. 2025-03-28

    Set for hearing April 7.

  7. 2025-04-07

    April 7 hearing: Placed on APPR. suspense file.

  8. 2025-05-16

    Set for hearing May 23.

  9. 2025-05-23

    Read second time. Ordered to third reading.

    reading-1,reading-2,reading-3

  10. 2025-05-23

    From committee: Do pass. (Ayes 6. Noes 0. Page 1187.) (May 23).

    committee-passage,committee-passage-favorable

  11. 2025-06-03

    Read third time. Passed. (Ayes 38. Noes 0. Page 1472.) Ordered to the Assembly.

    passage,reading-1,reading-3

  12. 2025-06-04

    In Assembly. Read first time. Held at Desk.

    reading-1

  13. 2025-06-09

    Referred to Com. on PUB. S.

    referral-committee

  14. 2025-07-02

    From committee: Do pass and re-refer to Com. on APPR. (Ayes 9. Noes 0.) (July 1). Re-referred to Com. on APPR.

    committee-passage,committee-passage-favorable,referral-committee

  15. 2025-07-16

    July 16 set for first hearing. Placed on APPR. suspense file.

  16. 2025-08-29

    August 29 hearing: Held in committee and under submission.

Versions

Documents

Votes

  • Do pass, but first be re-referred to the Committee on [Appropriations]

    2025-03-25 · pass · 6-0

    Member-level votes (6)
    • Arreguín: yes
    • Caballero: yes
    • Pérez: yes
    • Gonzalez: yes
    • Wiener: yes
    • Seyarto: yes
  • Placed on suspense file

    2025-04-07 · pass · 7-0

    Member-level votes (7)
    • Richardson: yes
    • Cabaldon: yes
    • Grayson: yes
    • Caballero: yes
    • Seyarto: yes
    • Wahab: yes
    • Dahle: yes
  • Do pass

    2025-05-23 · pass · 6-0

    Member-level votes (7)
    • Caballero: yes
    • Seyarto: yes
    • Wahab: yes
    • Cabaldon: yes
    • Richardson: yes
    • Grayson: yes
    • Dahle: other
  • 3rd Reading

    2025-06-03 · pass · 38-0

    Member-level votes (40)
    • Valladares: yes
    • Gonzalez: yes
    • Choi: yes
    • McNerney: yes
    • Weber Pierson: yes
    • Becker: yes
    • Laird: yes
    • Ashby: yes
    • Richardson: yes
    • Cervantes: yes
    • Padilla: yes
    • Stern: yes
    • Durazo: yes
    • Arreguín: yes
    • Seyarto: yes
    • Niello: yes
    • Cortese: yes
    • Hurtado: yes
    • Pérez: yes
    • Grove: yes
    • Cabaldon: yes
    • Dahle: yes
    • Grayson: yes
    • Allen: yes
    • Menjivar: yes
    • Strickland: yes
    • Wiener: yes
    • Archuleta: yes
    • Alvarado-Gil: yes
    • McGuire: yes
    • Blakespear: yes
    • Jones: yes
    • Wahab: yes
    • Limón: yes
    • Caballero: yes
    • Ochoa Bogh: yes
    • Rubio: yes
    • Umberg: yes
    • Reyes: other
    • Smallwood-Cuevas: other
  • Do pass and be re-referred to the Committee on [Appropriations]

    2025-07-01 · pass · 9-0

    Member-level votes (9)
    • Alanis: yes
    • Schultz: yes
    • Mark González: yes
    • Harabedian: yes
    • Ramos: yes
    • Nguyen: yes
    • Sharp-Collins: yes
    • Haney: yes
    • Lackey: yes

Related bills

No related bills recorded for this bill.

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T01:34:27.960412Z

Inspect retained evidence for changes recorded after evidence tracking began:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=CA&identifier=SB 6. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.
  • Some documents have no extracted text yet, so version comparison may be limited.

See the methodology page for data sources and limitations.